New leaders appointed to top U.S. federal health agencies

On April 16, 2026, the U.S. administration announced a significant leadership overhaul at the Centers for Disease Control and Prevention (CDC).

Following months of instability, President Donald Trump nominated Dr.

Schwartz, a retired Rear Admiral, aims to restore the agency's scientific reputation alongside a new team, including Chief Operating Officer Sean Slovenski and Chief Medical Officer Dr.

Critics worry about the politicization of public health, while observers hope these appointments signal a return to traditional medical expertise.

Mulligan also joining as HHS Chief Economist, the administration faces the difficult task of rebuilding staff trust while addressing backlogs in critical health data.

Whether this strategic shift will stabilize the agency or lead to further friction remains a subject of intense debate in Washington.